Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

6 July 2010

Leucine-rich, glioma-inactivated 1{LGI1} Identified as Autoantigen Associated With Limbic Encephalitis

Researchers have identified LGI1 (leucine-rich, glioma-inactivated 1) rather than voltage-gated potassium channels as the autoantigen associated with limbic encephalitis, a finding that may change diagnosis and classification of the disorder.
6 July 2010

Indian regulator GEAC approves 17 Bt crops for trials

Even as the moratorium announced by Environment Ministry of India against Bt brinjal in February 2010 continues, the biotech regulator has approved field trials of 17 new genetically modified (GM) crops in the country, bringing smiles to the BioAgri industry and frown on the faces of anti-GM activists.
6 July 2010

FICCI, DOP to organize National Convention on Biopharma in India

Considering the fact that India is a significant player in the global biopharmaceutical industry, the Federation of Chamber of Commerce of India (FICCI) and the Department of Pharmaceuticals (DOP), Government of India, are all set to organize a one-day “National Convention on Biopharma” on July 12, 2010, at Federation House, New Delhi.

[adsense:336x280:8701650588]
6 July 2010

Atorvastatin Beats Rosuvastatin in Protecting Kidneys in Diabetic and Nondiabetic Patients

July 2, 2010 (Munich, Germany) — Results of 2 related trials investigating the effects of statins on urinary protein excretion and kidney function found atorvastatin (ATV) protective and rosuvastatin (RSV) unprotective, and possibly harmful, in diabetic and nondiabetic patients.
6 July 2010

Study says normal adult blood can generate pluripotent stem cells

In findings likely to make it easier and faster for stem cell biologists to generate patient-specific embryonic-like stem cells, researchers at Children's Hospital Boston have reprogrammed adult blood cells into induced pluripotent stem (iPS) cells.
6 July 2010

NEWS: Intercell vaccine patch fails Phase II clinical trial

Intercell's investigational vaccine enhancement patch system for avian H5N1 influenza has failed a Phase II study. The company is working under a contract with Human and Health services (HHS) to develop a dose-sparing approach with potential for a single dose immunization combining a H5N1 vaccine with Intercell's LT adjuvant patch.

[adsense:336x280:8701650588]
6 July 2010

Roches new DNA sequencer opens innovation in genomic research

Roche Diagnostics has announced the Asia Pacific launch of the GS Junior System, the company’s new next-generation DNA sequencing platform for life science research. The GS Junior System, developed by 454 Life Sciences, a Roche company, provides an integrated sequencing and bioinformatics solution, all in a size that is no bigger than a typical desktop laser printer.
14 June 2010

The 62nd Indian Pharmaceutical Congress will be held in Manipal

The 62nd Indian Pharmaceutical Congress (IPC), hosted by Indian Hospital Pharmacists’ Association (IHPA), will be held from December 17 to 19, 2010 in Manipal University.
7 June 2010

New standard care of Advanced Melanoma presented in ASCO 2010 annual meeting

June 6, 2010 (Chicago, Illinois) — An experimental therapy for advanced melanoma has been shown to improve overall survival in patients, and is "on the road" to becoming the "new standard of care," said one of its investigators here at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting.
7 June 2010

Karnataka pharma majors bullish over European export prospects

Liquidity crunch and growing uncertainty in the Euro zone have not deterred the Karnataka-based pharma companies from expanding their operations and also patent filing in Europe.

[adsense:336x280:8701650588]